Profusa Receives Favorable Nasdaq Listing Determination

Market Intelligence Analysis

AI-Powered
Why This Matters

Financial market analysis indicating neutral sentiment based on current trends.

Sentiment
Neutral
AI Confidence
50%
Time Horizon
Short Term
Affected Symbols

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

BERKELEY, CA, May 08, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (“Profusa” or the “Company”) (Nasdaq: PFSA), a digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual’s biochemistry, announced that, by letter dated May 6, 2026, the Nasdaq Hearings Panel granted the Company’s request to transfer the listing of its securities from The Nasdaq Global Market to The Nasdaq Capital Market. The Company’s continued listing on Nasdaq is

Continue Reading
Full article on Yahoo Finance
Read Full Article
AI Breakdown

Summary

Financial market analysis indicating neutral sentiment based on current trends.

Time Horizon

Short Term

Original article published by Yahoo Finance on May 8, 2026.
Analysis and insights provided by AnalystMarkets AI.